High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation - Wikidata - wikimedia - TriplyDB

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

http://www.wikidata.org/entity/Q34657652

about

Clinical manufacturing of CAR T cells: foundation of a promising therapy Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy T-Cell Therapy: Options for Infectious Diseases Progress and prospects for engineered T cell therapies Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Genetic engineering with T cell receptors Clinical application of adoptive T cell therapy in solid tumors Mechanical oscillations enhance gene delivery into suspended cells.Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines.Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation.The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer The basic principles of chimeric antigen receptor design.Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects.Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis Engineering improved T cell receptors using an alanine-scan guided T cell display selection system Genetically engineered T cells for the treatment of cancer.An efficient low cost method for gene transfer to T lymphocytes Visible and near infrared resonance plasmonic enhanced nanosecond laser optoporation of cancer cells.Transduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic ma Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells.Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene.Engineering lymphocyte subsets: tools, trials and tribulations Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.Manipulation of cell membrane using carbon nanotube scaffold as a photoresponsive stimuli generator.A T-cell receptor associated with naturally occurring human tumor immunity.CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity.Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor

P2860

Q26747037-4D128DCD-A11A-4B4A-A87E-E65B8406DCDA Q26773309-4B07CCD2-3B31-459E-A055-276562A227E6 Q26786661-C04700CE-B8FC-432C-AB16-6B9C3A1D2C43 Q26852923-4E0F8807-E9E9-4D2C-B249-5D0AC8C9C451 Q26861563-EE2B7286-3212-44F4-9E80-8449ABAB8C2A Q26995677-983E0A71-BC57-40FD-94E4-F59BED40581A Q27011283-2C76C698-3696-44F2-9C37-F14C44826779 Q27333643-8B47DF3C-6565-42C2-B0BF-9C98E212B060 Q28067306-0872C628-2AF0-4E2E-BC29-2E9BFE0AE299 Q28727481-73B2F8B8-E4DD-4F4B-9F14-DC4E9E9E3C33 Q30303138-00520CB8-5AF5-4E02-B4D2-0FD03B887487 Q30515819-1D2252BD-D5D9-4AEA-AB09-04BC38F76504 Q33303162-28856A0A-50EE-48F0-9C97-E2F6C59D59DD Q33874986-8E5E8FD9-8EAB-4178-B4F6-DED243922A23 Q33993529-F922BC04-B2C9-4B75-A8A4-70890214BC94 Q34036213-FF6E55AC-30D6-4E90-A16F-6EE42B004373 Q34256494-060B5810-4336-48EB-88FB-C4100C273BBF Q34415755-3E853246-A706-444D-A26B-E1F00CA7DCDA Q34624124-46A186E8-BD0E-4472-B550-EE97BFE11224 Q34645898-82DD28A9-1305-4B45-8F92-679D0F37FF43 Q34653719-DA8786B2-F7ED-4F85-AADF-8EF4D1155391 Q34664238-563EACC8-3DE4-4405-8820-3A080AB0A42A Q34795354-315CF325-04B6-41F9-A73E-33AEF5790ADC Q35605318-B852514A-ACBE-45E9-A59A-49BF4D088347 Q35638571-1A352F4B-37BE-4F28-BCE7-C3CA7C75371E Q35677421-B98030E4-DAC6-4D2C-B52A-760E1DBA8D3A Q35839860-246685E3-9C80-4326-AE4D-C0E493BCB313 Q36140986-E1C83464-F1EB-4255-8C06-6745BAACD2C2 Q36165605-B2B0A077-BDB0-4161-97C8-2F829D51CF76 Q36201955-ECD425FD-F4AA-44D7-90A0-C0C24BD54C03 Q36277223-B957870D-0967-4197-9E2F-C72DAA862C52 Q36279306-A5692F57-D92E-4311-960A-FB9EDD2B9137 Q36286122-7D4A814D-2938-4411-BAA8-4DBE6C7704D1 Q36286127-8CAB9D62-4B65-41AE-B5AE-5997CE2FD4BD Q36311669-C1A66C70-5327-429F-A512-F7A93A31C0A6 Q36326582-4B3F19C2-09E4-4798-9737-6FFD88370335 Q36360773-09BF09DC-2452-4D95-B62C-EF3A42BB6A42 Q36470354-5204C3E3-BF69-4B2F-8802-50C1DCC4CB95 Q36547199-0F338575-B832-4186-97BB-E83D26B0EF8C Q36557169-1486D2EF-46A8-4B19-97F2-6E3F400CCEB1

P2860

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

http://www.wikidata.org/entity/Q34657652

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

High-efficiency transfection o ...... ytes using RNA electroporation

@ast

High-efficiency transfection o ...... ytes using RNA electroporation

@en

High-efficiency transfection o ...... ytes using RNA electroporation

@nl

type

label

High-efficiency transfection o ...... ytes using RNA electroporation

@ast

High-efficiency transfection o ...... ytes using RNA electroporation

@en

High-efficiency transfection o ...... ytes using RNA electroporation

@nl

prefLabel

High-efficiency transfection o ...... ytes using RNA electroporation

@ast

High-efficiency transfection o ...... ytes using RNA electroporation

@en

High-efficiency transfection o ...... ytes using RNA electroporation

@nl

P1433

Q34657652-8FC4730E-A43D-4AE1-9364-3564EDA528F3

P1476

Q34657652-97C7E0C7-DC31-4898-A478-ACC1161B819F

P2093

Q34657652-3CC8092F-706A-40D1-A33C-EB6704828236

Q34657652-9D0D4E1F-3E86-4A18-8089-47C32DC25D57

Q34657652-B5943B2A-75F2-42A3-A3A0-714128E30981

Q34657652-DCF61FC0-4C38-4012-BDFD-61CE914C776C

Q34657652-EC94BD4B-6EA7-4293-8E23-BFC0FDA04922

P2860

Q34657652-0CC9993E-EF1C-462C-B496-167B242C0CF3

Q34657652-12454283-A7CD-46A8-BB77-631103C5F1F7

Q34657652-127C6ED8-D35E-41CF-81C2-784D0A01911A

Q34657652-249E5148-7269-4608-85BA-0A1A7FF315E2

Q34657652-287D28DE-975A-4EB2-9A26-24D29D808FA8

Q34657652-2DA42D2E-9C5B-44DF-AFAE-EBC97F705DE6

Q34657652-3F56D626-203A-4758-BEA4-7B8235C3840C

Q34657652-40E30DBB-E017-4213-B88A-4A301C41BAF3

Q34657652-495EEE88-5D7C-457B-9F5F-701EFEBA5279

Q34657652-5071799D-B999-41D0-9B7D-3D4B5C071D23

P304

Q34657652-DB4B2A20-46AC-495C-BDDE-B8B733702484

P31

Q34657652-F60B3BA6-5125-4423-A015-0914DBF3F42E

P356

Q34657652-5B528AFF-8203-447A-9E5B-DF150D7307A2

P433

Q34657652-B8F74446-1E01-4247-860E-3571557A9AE0

P478

Q34657652-A8631A42-8BF3-4257-9B84-675AB54DDCDD

P50

Q34657652-078EEE3C-7E6F-4902-BD0F-F2DD58CEE6DA

Q34657652-FD8BC7C9-F46F-486E-B418-DB5FF49E3CA1

Q34657652-FFCEC84A-D045-4855-A4EE-B5F2CD80541E

P577

Q34657652-FF44F849-FB67-4CD7-8F17-3BA09C6D6FD4

P5875

Q34657652-95C2576E-70D0-4582-B03C-C892BAA80476

P698

Q34657652-92F1D2B0-24FC-4F09-AB02-CFC6B0DC755C

P921

Q34657652-9ECB8D34-395F-4506-BA08-4D195CFEA03D

P932

Q34657652-970A4B2D-9D0E-47BA-91C9-B1B7BDA8C9DF

P356

J.YMTHE.2005.07.688

P1433

Molecular Therapy

P1476

High-efficiency transfection o ...... ytes using RNA electroporation

@en

P2093

Luca Gattinoni

http://www.w3.org/2001/XMLSchema#string

Richard A Morgan

http://www.w3.org/2001/XMLSchema#string

Steven A Rosenberg

http://www.w3.org/2001/XMLSchema#string

Yangbing Zhao

http://www.w3.org/2001/XMLSchema#string

Zhili Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Emerging clinical applications of RNA

Targeting p53 as a general tumor antigen.

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

A non-viral gene delivery system designed for clinical use.

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production.

CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients.

High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.

P304

151-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2005.07.688

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas P. Restifo

P577

2005-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7619909

http://www.w3.org/2001/XMLSchema#string

P698

16140584

http://www.w3.org/2001/XMLSchema#string

P921

electroporation

P932

1473967

http://www.w3.org/2001/XMLSchema#string